Kringle Pharma, Inc. Share · JP3270790003 (XTKS) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak

AI-Powered Analysis

Fundamental Analysis

Find out what the numbers really say — before the market does

Analyze now

News Sentiment

Are today's headlines a buy signal or a red flag?

Analyze now

Buy / Hold / Sell

Should you Buy, Hold, or Sell? Get the AI verdict now.

Analyze now

Risk Assessment

Uncover hidden risks before they hit your portfolio.

Analyze now

Fair Value

Is this stock cheap, fairly priced, or overvalued?

Analyze now

Latest AI Analyses of Kringle Pharma, Inc.

No Price

Closing Price XTKS 01.05.2026: 475,00 JPY

01.05.2026 05:41

Current Prices from Kringle Pharma, Inc.

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
Tokyo	4884.T	JPY	01.05.2026 05:41	475,00 JPY	14,00 JPY +3,04 %

Share Float & Liquidity

Free Float 89,67 %

Shares Float 6,51 M

Shares Outstanding 7,26 M

Company Profile for Kringle Pharma, Inc. Share

Kringle Pharma, Inc. engages in the research and development, manufactures, and sells hepatocyte growth factor (HGF) protein pharmaceuticals for regenerative medicines. The company develops HGF products for the treatment of acute spinal cord injury, amyotrophic lateral sclerosis, vocal fold scar, and acute kidney injury. Kringle Pharma, Inc. was incorporated in 2001 and is based in Ibaraki, Japan.

Company Data

Name Kringle Pharma, Inc.

Company Kringle Pharma, Inc.

Website https://www.kringle-pharma.com

Primary Exchange

Tokyo

ISIN JP3270790003

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Kiichi Adachi

Market Capitalization 3 Mrd.

Country Japan

Currency JPY

Employees 0,0 T

Address 207 Saito Bio Incubator, 567-0085 Ibaraki

IPO Date 2020-12-28

Ticker Symbols

Name	Symbol
Tokyo	4884.T

More Shares

Investors who hold Kringle Pharma, Inc. also have the following shares in their portfolio:

ARCPACIFIC RES INC Share

BNPP LAT.AMER.EQ. CL.DIS. Fund